Citations

Showing 10 of 108094 citations.

The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation
Wang, Qi , Guo, Lei , Jack, Clifford R. , Zhou, Jiayu , Jack, Clifford R , Guo, Lei, Thompson, Paul M. , Dodge, Hiroko Hayama , Zhan, Liang

Mayo Clinic

Journal of Alzheimer’s Disease | June 1, 2018 | Volume: 64 | Issue: 1 | Pages: 149-169

10.3233/jad-171048 | PMID 29865049 Get It

T1-weighted MRI has been extensively used to extract imaging biomarkers and build classification models for differentiating Alzheimer’s disease (AD) patients from healthy controls, but only recently have brain connectome networks derived from diffusion-weighted MRI been used to model AD progression and various stages of disease such as mild cognitive impairment (MCI). MCI, as a possible prodromal stage of AD, has gained intense interest recently, since it may be used to assess risk factors for AD. Little work has been done to combine information from both white matter and gray matter, and it is unknown how much classification power the diffusion-weighted MRI-derived structural connectome could provide beyond information available from T1-weighted MRI. In this paper, we focused on investigating whether diffusion-weighted MRI-derived structural connectome can improve differentiating healthy controls subjects from those with MCI. Specifically, we proposed a novel feature-ranking method to build classification models using the most highly ranked feature variables to classify MCI with healthy controls. We verified our method on two independent cohorts including the second stage of Alzheimer’s Disease Neuroimaging Initiative (ADNI2) database and the National Alzheimer’s Coordinating Center (NACC) database. Our results indicated that 1) diffusion-weighted MRI-derived structural connectome can complement T1-weighted MRI in the classification task; 2) the feature-rank method is effective because of the identified consistent T1-weighted MRI and network feature variables on ADNI2 and NACC. Furthermore, by comparing the top-ranked feature variables from ADNI2, NACC, and combined dataset, we concluded that cross-validation using independent cohorts is necessary and highly recommended.
A pharmacological challenge predicts reversible rectal sensorimotor dysfunctions in women with fecal incontinence
Sharma, Mayank , Feuerhak, Kelly, Zinsmeister, Alan R., Bharucha, Adil E. , Bharucha, A E

Mayo Clinic

Neurogastroenterology & Motility | June 1, 2018 | Volume: 30 | Issue: 10 | Pages: No page available

10.1111/nmo.13383 | PMID 29856103 Get It

AbstractBackgroundIn order to understand the pathophysiology of rectal sensorimotor dysfunctions in women with fecal incontinence (FI) and rectal urgency, we evaluated the effects of a muscarinic antagonist and an adrenergic α2 agonist on these parameters.MethodsFirstly, rectal distensibility and sensation were evaluated with a barostat and sinusoidal oscillation at baseline and after randomization to intravenous saline or atropine in 16 healthy controls and 44 FI patients. Thereafter, FI patients were randomized to placebo or clonidine for 4 wk; rectal compliance and sensation were revaluated thereafter. The effect of atropine and clonidine on rectal functions and the relationship between them were evaluated.ResultsAt baseline, compared to controls, rectal capacity was lower (P = .03) while the mean pressure (P = .02) and elastance (P = .01) during sinusoidal oscillation were greater, signifying reduced distensibility, in FI. Compared to placebo, atropine increased (P ≤ .02) the heart rate in controls and FI and reduced (P = .03) the variability in rectal pressures during sinusoidal oscillation in controls. Clonidine increased rectal compliance (P = .04) and reduced rectal capacity (P = .03) in FI. The effects of atropine and clonidine on compliance (r = .44, P = .003), capacity (r = .34, P = .02), pressures during sinusoidal oscillation (r = .3, P = .057), pressure (r = .6, P < .0001), and volume sensory thresholds (r = .48, P = .003) were correlated.ConclusionsThe effects of atropine and clonidine on rectal distensibility and sensation were significantly correlated. A preserved response to atropine suggests that reduced rectal distensibility is partly reversible, mediated by cholinergic mechanisms, and may predict the response to clonidine, providing a pharmacological challenge.
Cytotoxic Effects of Nonionic Iodinated Contrast Agent on Human Adipose‐Derived Mesenchymal Stem Cells
Wu, Tao , Nie, Hai , Dietz, Allan B. , Šálek, David, Smith, Jay , Wijnen, André J. van , Qu, Wenchun , Salek, David R, van Wijnen, Andre J , Dietz, Allan B

Mayo Clinic

PM&R | June 1, 2018 | Volume: 11 | Issue: 1 | Pages: 45-55

10.1016/j.pmrj.2018.05.022 | PMID 29860023 Get It

BackgroundTransplantation of mesenchymal stem cells (MSCs) is a promising therapy for degenerative spine conditions. However, cell therapy for painful spine degeneration presently requires use of contrast agents during fluoroscopy‐guided injections, and the effects of these agents on MSCs represents a gap in knowledge.ObjectiveTo investigate the biological effects of contrast media (CM) that are coinjected with MSCs.DesignProspective observational study.SettingAcademic medical center.ParticipantsPatient‐derived clinical‐grade culture expanded MSCs.InterventionsIohexol (Omnipaque300) was reduced to 12.5%, 25%, 50%, and 100% of the stock solution and incubated with MSCs for 30 minutes, 4 hours, and 48 hours. We also used complete media and 12.5%, 25%, 50%, 100% of phosphate‐buffered saline as a control group.Main Outcome MeasuresWe examined cytotoxicity of iohexol at different concentrations and exposure duration, as well as the potential for recovery over time. Cell counts, mitochondrial activity, and quantitative real time reverse‐transcriptase polymerase chain reaction of related genes were analyzed immediately after exposure (day 0) and after 2 days of exposure (day 2).ResultsHuman MSCs exhibit a time‐ and concentration‐dependent cytotoxic response to iodinated CM. A brief, 30‐minute exposure did not affect MSCs function and viability. However, extended treatment with iohexol for 4 hours at 50% or higher concentration had a significant impact on both viability and gene expression in MSCs.ConclusionsIohexol is cytotoxic to MSCs in a time‐and concentration‐dependent manner. Hence, the concentration of CM that accompanies MSC injections should be carefully considered during MSC therapy for disk‐degenerative diseases.Level of EvidenceIII.
What Do You Want From Your Echocardiogram?
Reddy, Yogesh N.V. , Borlaug, Barry A. , Nishimura, Rick , Borlaug, Barry A

Mayo Clinic

Journal of the American Heart Association | June 1, 2018 | Volume: 7 | Issue: 11 | Pages: No page available

10.1161/jaha.118.009462 | PMID 29858373 Get It

Reverse Shoulder Arthroplasty With Proximal Humeral Replacement for the Management of Massive Proximal Humeral Bone Loss
Lee, Julia , Mangold, Devin R., Cofield, Robert H. , Sperling, John W. , Shukla, Dave R. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Shoulder and Elbow Arthroplasty | June 1, 2018 | Volume: 2 | Issue: No issue available | Pages: No page available

10.1177/2471549218779845 Get It

Background Substantial proximal humeral bone loss may compromise reverse shoulder arthroplasty secondary to limited implant support, insufficient soft tissue tension due to shortening, lack of attachment sites for the posterosuperior cuff when present, and lack of lateral offset of the deltoid. In these circumstances, use of a proximal humeral replacement may be considered. Patients/Methods Between 2012 and 2014, 34 consecutive reverse shoulder arthroplasties were performed using a proximal humeral replacement system. The indications were failed shoulder arthroplasty (15), oncology reconstruction (9), humeral malunion/nonunion (7), prior resection arthroplasty (2), and intraoperative fracture (1). All patients were included in the survival analysis. Twenty-two patients with minimum 2-year follow-up were included in analysis of clinical results. Results Among the cohort of 34 patients, there were 8 additional reoperations: humeral loosening (3), periprosthetic fracture (2), irrigation and debridement (2), and glenoid loosening (1). Humeral component loosening occurred exclusively in patients undergoing revision shoulder arthroplasty. The 4 patients had an average 3.75 prior procedures before the proximal humeral replacement. Two of the revisions were from cemented to uncemented stems. Among the 23 patients with minimum 2-year follow-up, there was significant improvement in pain scores (4.1 vs 0.6), forward elevation (31 vs 109) degrees, and 81% were satisfied. Conclusion Use of a proximal humeral replacement when performing a reverse shoulder arthroplasty in the complex setting of substantial proximal humerus bone loss provides good clinical results and a particularly low dislocation rate. However, the rate of loosening of the humeral component in the revision setting suggests that proximal humeral replacement components should be cemented when revising a previously cemented stem. IRB 16-006966.
Integrating artificial intelligence with real-time intracranial EEG monitoring to automate interictal identification of seizure onset zones in focal epilepsy
Varatharajah, Yogatheesan , Berry, Brent , Cimbálník, Jan , Křemen, Václav , Stead, Matt, Brinkmann, Benjamin H. , Van Gompel, Jamie, Brinkmann, Benjamin, Brinkmann, Benjamin H , Kremen, Vaclav , Gompel, Jamie J. Van , Iyer, Ravishankar K. , Worrell, Gregory A.

Mayo Clinic

Journal of Neural Engineering | June 1, 2018 | Volume: 15 | Issue: 4 | Pages: 046035

10.1088/1741-2552/aac960 | PMID 29855436 Get It

Abstract Objective . An ability to map seizure-generating brain tissue, i.e. the seizure onset zone (SOZ), without recording actual seizures could reduce the duration of invasive EEG monitoring for patients with drug-resistant epilepsy. A widely-adopted practice in the literature is to compare the incidence (events/time) of putative pathological electrophysiological biomarkers associated with epileptic brain tissue with the SOZ determined from spontaneous seizures recorded with intracranial EEG, primarily using a single biomarker. Clinical translation of the previous efforts suffers from their inability to generalize across multiple patients because of (a) the inter-patient variability and (b) the temporal variability in the epileptogenic activity. Approach . Here, we report an artificial intelligence-based approach for combining multiple interictal electrophysiological biomarkers and their temporal characteristics as a way of accounting for the above barriers and show that it can reliably identify seizure onset zones in a study cohort of 82 patients who underwent evaluation for drug-resistant epilepsy. Main results . Our investigation provides evidence that utilizing the complementary information provided by multiple electrophysiological biomarkers and their temporal characteristics can significantly improve the localization potential compared to previously published single-biomarker incidence-based approaches, resulting in an average area under ROC curve (AUC) value of 0.73 in a cohort of 82 patients. Our results also suggest that recording durations between 90 min and 2 h are sufficient to localize SOZs with accuracies that may prove clinically relevant. Significance . The successful validation of our approach on a large cohort of 82 patients warrants future investigation on the feasibility of utilizing intra-operative EEG monitoring and artificial intelligence to localize epileptogenic brain tissue. Broadly, our study demonstrates the use of artificial intelligence coupled with careful feature engineering in augmenting clinical decision making.
Prolonged Human Survival Alone At Sea: A Prospective Study
Mallory, Douglas L., Winkelmann, R.K., Butterfield, G. E., Horvath, Steven M., Thomas, Harry M., Bachrach, Arthur J., Mohler, Pamela A., Bird, Peter, Palumbo, Pasquale J

Mayo Clinic

Military Medicine | June 1, 2018 | Volume: 153 | Issue: 9 | Pages: 459-464

10.1093/milmed/153.9.459 Get It

Diagnostic evaluation and management of culture‐negative cardiovascular implantable electronic device infections
Garrigos, Zerelda Esquer , George, Merit P., Farid, Saira, Saleh, Omar Abu , Vijayvargiya, Prakhar , Mahmood, Maryam , Friedman, Paul A. , Steckelberg, James M., DeSimone, Daniel C. , Wilson, Walter R. , Sohail, M. Rizwan , Esquer Garrigos, Zerelda , Abu Saleh, Omar M, Sohail, M Rizwan , DeSimone, Daniel C , Mahmood, Maryam , Baddour, Larry M.

Mayo Clinic

Pacing and Clinical Electrophysiology | June 1, 2018 | Volume: 41 | Issue: 8 | Pages: 933-942

10.1111/pace.13397 | PMID 29855048 Get It

AbstractBackgroundCulture‐negative (CN) cardiovascular implantable electronic device (CIED) infections represent a significant management challenge for clinicians with no specific guidelines addressing this subgroup of patients. The aim of the current investigation is to report our institutional experience of CN CIED infections and propose a systematic approach to diagnostic evaluation and management of these complicated cases based on our observations.MethodsWe retrospectively screened all CIED infection cases at Mayo Clinic from 2005 through 2017. Using standardized criteria to define significant microbial growth, all patients with positive blood or pocket/device cultures were excluded.ResultsA total of 835 cases of CIED infection were screened, and of these, 47 (6%) met CN‐CIED infection criteria. Majority of patients (77%) in this cohort had received antimicrobial therapy prior to device cultures with a median duration of 8 days. The most common presentation was device pocket infection (81%). All patients underwent device removal. Route of antibiotics was switched from oral to parenteral and spectrum of activity expanded from initial therapy in 23% of patients despite negative cultures. Majority of patients (80%) were dismissed on parenteral therapy. Adverse events attributed to intravenous antibiotic therapy were documented in 63% of the cases. No recurrence was reported and 6‐month survival was 94.8%.ConclusionsPocket and device cultures in suspected CIED infections may be negative due to preextraction oral antibiotics. However, frequently these patients are managed with broad‐spectrum parenteral therapy postextraction.